Efficacy of Peptide Receptor Radionuclide Therapy for Functional Metastatic Paraganglioma and Pheochromocytoma

Peptide Receptor Radionuclide Treatment and (131)I-MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas

(2017) Konstantinos Nastos et al.   JOURNAL OF SURGICAL ONCOLOGY

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

(2017) Jonathan Strosberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

PET/CT comparing 68Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma

(2016) Ingo Janssen et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Peptide receptor radionuclide therapy for metastatic paragangliomas

(2016) David J. Pinato et al.   MEDICAL ONCOLOGY

68Ga-DOTATATE and 18F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity

(2016) Chian A. Chang et al.   CANCER IMAGING

Moving Beyond "Lumpology": PET/CT Imaging of Pheochromocytoma and Paraganglioma

(2015) M. S. Hofman et al.   CLINICAL CANCER RESEARCH

15 YEARS OF PARAGANGLIOMA: Imaging and imaging-based treatment of pheochromocytoma and paraganglioma

(2015) Frédéric Castinetti et al.   ENDOCRINE-RELATED CANCER

Peptide receptor radionuclide therapy with 90Y/177Lu-labelled peptides for inoperable head and neck paragangliomas (glomus tumours)

(2015) Ameya D. Puranik et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Prospective comparison of 68Ga-DOTATATE and 18F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases

(2015) Aurélien Archier et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI

(2015) I. Janssen et al.   JOURNAL OF NUCLEAR MEDICINE

The genomic landscape of phaeochromocytoma

(2015) Aidan Flynn et al.   JOURNAL OF PATHOLOGY

Radiation safety of outpatient 177Lu-octreotate radiopeptide therapy of neuroendocrine tumors

(2014) Phillipe J. Calais et al.   ANNALS OF NUCLEAR MEDICINE

Effects and safety of 131I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: Results from a multicenter observational registry

(2014) Keiichiro Yoshinaga et al.   ENDOCRINE JOURNAL

131I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis

(2013) L. T. van Hulsteijn et al.   CLINICAL ENDOCRINOLOGY

EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma

(2012) David Taïeb et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE in Individuals with Neck or Mediastinal Paraganglioma (PGL)

(2012) S. Zovato et al.   HORMONE AND METABOLIC RESEARCH

Treatment with Sunitinib for Patients with Progressive Metastatic Pheochromocytomas and Sympathetic Paragangliomas

(2012) Montserrat Ayala-Ramirez et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma

(2011) Nelly Burnichon et al.   HUMAN MOLECULAR GENETICS

Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma

(2010) G. Eisenhofer et al.   ENDOCRINE-RELATED CANCER

Clinical aspects of SDHx-related pheochromocytoma and paraganglioma

(2009) Henri J L M Timmers et al.   ENDOCRINE-RELATED CANCER

Survival of Patients with Metastatic Malignant Pheochromocytoma and Efficacy of Combined Cyclophosphamide, Vincristine, and Dacarbazine Chemotherapy

(2009) Kaoru Nomura et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Phase II Study of High-Dose [131I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma

(2009) Sara Gonias et al.   JOURNAL OF CLINICAL ONCOLOGY

Usefulness of 123I-MIBG Scintigraphy in the Evaluation of Patients with Known or Suspected Primary or Metastatic Pheochromocytoma or Paraganglioma: Results from a Prospective Multicenter Trial

(2009) G. A. Wiseman et al.   JOURNAL OF NUCLEAR MEDICINE

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review of the literature

(2008) Alejandro L Rosas et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY